Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Fedor Panov

Neurological Surgery New York, NY Medical Doctor

NPI 1962661686 CMS profile 845984

1249 Park Ave Apt 10G, New York, NY 10029

Open in the dashboard

General payments

$121,639

199 records reported · program years 2019–2025

Research payments

$188

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$60,049 paid to institutions, not to them · program years 2020–2023

Through program year 2025, Fedor Panov of New York, NY is reported in the CMS Open Payments database as having received $121,639 across 199 general payments and $188 in research payments paid to them. Separately, studies naming them as principal investigator received $60,049 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $28,197 34
2024 General $17,957 42
2023 General $14,447 23
2022 General $22,093 39
2022 Research $188 1
2021 General $17,965 22
2020 General $7,859 8
2019 General $13,120 31

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Fedor Panov
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Fedor Panov were reported at $28,197. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Fedor Panov Neurological Surgery median Middle half National median
2019 $13,120 $582 $138–$3,006 $163
2020 $7,859 $294 $76–$2,174 $114
2021 $17,965 $387 $105–$2,432 $132
2022 $22,093 $542 $139–$2,989 $149
2023 $14,447 $534 $145–$2,697 $160
2024 $17,957 $574 $155–$3,046 $164
2025 $28,197 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. NeuroPace, Inc. $78,311 102 payments
  2. Zimmer Biomet Holdings, Inc. $35,151 37 payments
  3. Monteris Medical Corporation $2,489 13 payments
  4. Abbott Laboratories $1,344 15 payments
  5. Boston Scientific Corporation $1,042 8 payments
  6. ClearPoint Neuro, Inc. $983 10 payments
  7. InSightec,Inc $928 5 payments
  8. Microtransponder, Inc. $682 3 payments
  9. Medtronic, Inc. $535 4 payments
  10. Kyowa Kirin, Inc. $150 1 payment
  11. Other $27 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $98,486 65 payments
  2. Travel and Lodging $11,932 33 payments
  3. Food and Beverage $11,222 101 payments
Products named General payments · program years 2019–2025
  1. RNS Neurostimulator Kit $63,615 75 payments
  2. ROSA CMF & Thoracic $10,691 11 payments
  3. RNS System Epilepsy $9,005 17 payments
  4. CMF & Thoracic-None $8,000 6 payments
  5. ROSA CMF & Thoracic $6,786 9 payments
  6. RNS System Epilepsy $5,690 10 payments
  7. ROSA-Brain $2,750 2 payments
  8. Neuroblate $1,739 12 payments
  9. CLEARPOINT $983 10 payments
  10. INFINITY $875 8 payments
  11. Other $4,240 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Monteris Medical Corporation $188 1 payment

Billing to Medicare

Part B · data year 2024 · 37 billing codes

Paid by Medicare

$51,175

Medicare's payments for the services billed

Medicare patients

100

Average age 71

Services billed

214

52 women, 48 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 54%
Depression 36%
Diabetes 34%
Ischemic heart disease 30%
Chronic kidney disease 23%
Osteoporosis 22%
Alzheimer's or dementia 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
NOURIANZ
  • Kyowa Kirin, Inc. $150
$150 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

200 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in New York

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record